Status:

COMPLETED

The Metabolic Profile in Intrahepatic Cholestasis of Pregnancy and Diabetes Mellitus

Lead Sponsor:

Imperial College London

Conditions:

Intrahepatic Cholestasis of Pregnancy

Gestational Diabetes Mellitus

Eligibility:

FEMALE

16-70 years

Brief Summary

ICP is known to cause abnormal bile acid homeostasis and to be associated with an increased risk of diseases of the biliary system in later life. There have been small studies (Dann et al. 2006; Wójci...

Detailed Description

CLINICAL FEATURES OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY: Intrahepatic cholestasis of pregnancy (ICP), is a pregnancy-specific liver disorder which typically presents with maternal pruritus (itchin...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Women with intrahepatic cholestasis of pregnancy, defined as pruritus in pregnancy in association with raised serum bile acids and in the absence of an alternative cause.
  • Women with gestational diabetes mellitus (GDM) according to the diagnostic criteria used at the referring centre
  • Non-pregnant parous females with previous ICP or GDM.
  • Women who are able to give consent.
  • Women \>16 and \<70 years of age. Controls
  • Pregnant women not affected by ICP or GDM .
  • Non-pregnant parous females with previous uncomplicated pregnancy.
  • Women who are able to give consent.
  • Women \>16 and \<70 years of age.
  • Exclusion Criteria
  • Males.
  • Non-pregnant females with other medical disorders that can cause liver impairment, abnormal lipid or glucose metabolism in pregnancy, e.g. pre-eclampsia, acute fatty liver of pregnancy, pre-existing diabetes mellitus
  • Pregnant females with a history of other medical disorders that can cause liver impairment, abnormal lipid or glucose metabolism in pregnancy, e.g. pre-eclampsia, acute fatty liver of pregnancy, pre-existing diabetes mellitus
  • Women who are not able to give consent.
  • Women \<16 and \>70 years of age.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2011

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    April 30 2023

    Estimated Enrollment :

    116 Patients enrolled

    Trial Details

    Trial ID

    NCT01499524

    Start Date

    November 1 2011

    End Date

    April 30 2023

    Last Update

    April 3 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Guy's & St Thomas' NHS Foundation Trust

    London, United Kingdom, SE1 7EH

    2

    Imperial College Healthcare NHS Trust Hammersmith

    London, United Kingdom